Use of 2,5-dihydroxybenzenesulfonic derivatives for manufacture of medicaments for disorders of endothelial origin

摘要

PCT No. PCT/EP97/01709 Sec. 371 Date Oct. 1, 1998 Sec. 102(e) Date Oct. 1, 1998 PCT Filed Apr. 3, 1997 PCT Pub. No. WO97/37647 PCT Pub. Date Oct. 16, 1997Method for the use of 2,5,-dihydroxybenzenesulphonic derivatives for normalizing endothelial function and treating sexual dysfunctions, the vascular complications of diabetes and vascualr disorders of endothelial origin are disclosed. Preferred 2,5-dihydroxybenzenesulponic derivatives are calcium dobesilate, ethamsylate and persilate.